ABBOTINDIA / NSE / Biotechnology & Drugs
Abbott India
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High35,921.55
Target Low25,164
Target Mean1.57
Target Median71.43
Risk Metrics
Overall RiskModerate risk
Board Risk22.24
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Abbott India Ltd. is Rated Sell by MarketsMOJO Markets Mojo
Abbott India Ltd. Faces Bearish Momentum Amid Technical Downgrade Markets Mojo
Abbott India Q4 FY26: Margin Resilience Masks Profit Volatility Amid Premium Valuation Markets Mojo
Abbott India Ltd stock (INE358A01014): Q3 FY26 margin pressure keeps investors cautious AD HOC NEWS
Abbott India Limited Appoints Swati Pathak as Associate Director - Operations, Effective June 1, 202626 marketscreener.com
Abbott India appoints Swati Pathak as Associate Director - Operations scanx.trade
Abbott India Ltd. is Rated Sell Markets Mojo
Massive Rs 525 dividend alert! This company in Q4 results broke its own payout record of Rs 475 MSN
© SharekeyX | Rusaka Technologies 2024-2026

